D
uring the past 20 years, GII.4 genotypes have been responsible for most norovirus outbreaks globally (1) . New GII.4 variants have emerged every 2 or 3 years, replacing the previous dominant variant. Likewise, in Guangdong, China, as well as in other regions of China, GII.4 noroviruses have caused most outbreaks; several other genotypes, such as GI.3, GI.6, GII.6, and GII.21, were occasionally detected in sporadic cases but rarely caused large outbreaks (2) .
The Guangdong provincial surveillance network for foodborne disease outbreaks has been active since 2008 and is responsible for the surveillance of norovirus outbreaks in Guangdong. During winter 2014-15, a new GII.17 variant (GII.P17-GII.17 Kawasaki) was first identified in Guangdong and caused a substantial increase in the number of acute gastroenteritis outbreaks (3) . Epidemics caused by this lineage were detected almost simultaneously in several other provinces of China, and sporadic cases were reported worldwide (4) . We report an increase in the number of outbreaks associated with a GII.P16-GII.2 recombinant norovirus strain in the last months of 2016 in Guangdong.
The Study
In Guangdong, norovirus outbreaks are highly seasonal; most (>90%) are reported during November-March (3). In November 2014, a GII.17 variant was identified in Guangdong and became predominant during the 2014-15 and 2015-16 norovirus seasons (5) . After June 2016, the number of GII.17 outbreaks decreased, replaced by GII.4 outbreaks (Figure 1 ). During November and December 2016, a sharp increase in the number of norovirus outbreaks was reported in multiple cities of Guangdong through the provincial surveillance network ( Figure 1 ). Seventeen (81%) of the 21 outbreaks in 10 cities were typed as GII.2; these outbreaks resulted in 760 clinical cases ( Figure 1 ). This genotype was first detected in Guangzhou on November 14, 2016, and spread rapidly thereafter. The sharp increase in the number of outbreaks and the unusual GII.2 genotype prompted us to further characterize these viruses.
We randomly selected 5 fecal samples from each GII.2 outbreak for Sanger sequencing. The full length of RdRp and VP1 genes were sequenced by using specific oligonucleotide primer sets (online Technical Appendix Table, https://wwwnc.cdc.gov/EID/article/23/7/17-0333-Techapp1. pdf) Representative sequences were deposited in GenBank (accession nos. KY485107-KY485126). A primer set (JV12RY and JV13I [6] ) commonly used for RdRp typing failed to amplify the corresponding fragments of GII.2/ Guangdong/2016 strains because of mismatches with these primers. We compared the Guangdong GII.2 viruses with related VP1 (GII.2) and RdRp gene sequences (P16) from GenBank. Molecular clock phylogenetic analysis was performed to analyze the evolution of the VP1 gene sequences by using the Bayesian Markov chain Monte Carlo framework with a generalized time-reversible nucleotide substitution model (7) and an uncorrelated lognormal relaxed clock model (8) (Figure  2 ). Most GII. GII.P16 RdRp gene sequences of the Guangdong and Germany outbreaks were closely related with GII.P16 sequences from GII.4 Sydney viruses detected in Japan and the United States (online Technical Appendix Figure 2 ).
Conclusions
We report an increased number of norovirus GII. The number of GII.P16-GII.2 outbreaks peaked at the end of 2016, similar to the epidemic season caused by the GII. P17-GII.17 variant in 2014. The emergence of GII.2 viruses was almost simultaneously reported in several other regions of China (China National Surveillance Network for Foodborne Disease Outbreaks, February 2017) as well as in Germany (9), suggesting the fast spread of this genotype on multiple continents. As a result, the predominant norovirus genotype in Guangdong Province has changed from GII.4 viruses, of which a new variant emerged every 2 or 3 years, to non-GII.4 viruses with GII.17 during the 2014-15 winter season and GII.2 viruses during the 2016-17 season. Since the GII.17 variant has spread to several countries in Asia and has been reported on different continents, the effect of this emerging GII.2 recombinant strain warrants further global surveillance.
